Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1.84 % |
3 Month Return | + 8.67 % |
1 Year Return | -3.01 % |
Market Stats | |
Previous Close | ₹382.20 |
Open | ₹383.80 |
Volume | 98.46K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,054.81Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹1,054.81 Cr |
P/B Ratio | 2.9 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | -12.23 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹1,054.81 Cr | 1.06% | 0.79 | NA | NA | |
NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
Organisation | Bajaj Healthcare Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Bajaj Healthcare Ltd
Bajaj Healthcare has signed a development and supply agreement for an Active Pharmaceutical Ingredient (API) with a European entity, initially supplying small quantities for clinical trials. The partnership highlights the company's manufacturing capabilities and GMP compliance.
Bajaj Healthcare Approves Share Allotment - 19 Sep, 2024
On September 19, 2024, Bajaj Healthcare's board approved the preferential allotment of 39,84,852 equity shares and 20,79,409 convertible warrants at Rs. 338 each, totaling over Rs. 204 crore.
Bajaj Healthcare Declares 20% Dividend Amid Stock Surge - 18 Sep, 2024
Bajaj Healthcare announced a 20% final dividend of Rs 1 per share, subject to shareholder approval. The stock surged 4.32% to Rs 399.60, reflecting a 30.67% increase over six months and a 341.55% rise over five years.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 32.26% to 36.39% in Sep 2024 quarter
Price Rise
In the last 7 days, BAJAJHCARE stock has moved up by 1.5%
FII Holding Up
Foreign Institutions have increased holdings from 0.01% to 2.46% in Sep 2024 quarter
MF Holding Up
Mutual Funds have increased holdings from 0.00% to 1.31% in Sep 2024 quarter
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 86.8%
Promoter Holding Down
Promoters have decreased holdings from 67.73% to 59.19% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 59.19% | ||
Foreign Institutions | 2.46% | 43758.93 | |
Mutual Funds | 1.31% | 262340.00 | |
Retail Investors | 36.39% | 12.80 | |
Others | 0.66% | 36327.78 |
Bajaj Healthcare Ltd’s net profit jumped 114.79% since last year same period to ₹7.13Cr in the Q1 2024-2025. On a quarterly growth basis, Bajaj Healthcare Ltd has generated 123.83% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Bajaj Healthcare Ltd has declared dividend of ₹1 - translating a dividend yield of 0.53%.
Read More about DividendsBearish
Neutral
Bullish
Bajaj Healthcare Ltd is currently in a Bearish trading position according to technical analysis indicators.
Bajaj Healthcare Ltd (BAJAJHCARE) share price today is ₹379.25
Bajaj Healthcare Ltd is listed on NSE
Bajaj Healthcare Ltd is listed on BSE
Today’s traded volume of Bajaj Healthcare Ltd(BAJAJHCARE) is 98.46K.
Today’s market capitalisation of Bajaj Healthcare Ltd(BAJAJHCARE) is ₹1054.81Cr.
Bajaj Healthcare Ltd(BAJAJHCARE | Price |
---|---|
52 Week High | ₹472.3 |
52 Week Low | ₹263.3 |
Bajaj Healthcare Ltd(BAJAJHCARE) share price is ₹379.25. It is down -19.70% from its 52 Week High price of ₹472.3
Bajaj Healthcare Ltd(BAJAJHCARE) share price is ₹379.25. It is up 44.04% from its 52 Week Low price of ₹263.3
Bajaj Healthcare Ltd(BAJAJHCARE | Returns |
---|---|
1 Day Returns | -2.95% |
1 Month Returns | -1.84% |
3 Month Returns | 8.67% |
1 Year Returns | -3.01% |